DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update
DataMeds AI reported Q2 2026 revenue of $1.779 million, a 14% sequential increase, but a substantial decline from the $7.79 million reported in the same period last year. The company recorded a net operating loss of $18.36 million, significantly widening the $6.67 million loss from the prior year, driven largely by debt extinguishment expenses.
Key figures
- Revenue
- 1779860
- Guidance
- Launch of Health Lives Here consumer app targeting GLP-1 users expected in second half of 2026
- Net loss
- 18363225
- Funding raised usd
- 6500000
- Net loss prior year
- 6672464
- Reverse split ratio
- 1:50
- Debt restructured usd
- 14500000
- Token ratio per share
- 50
- Revenue seq growth pct
- 14
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.